HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Isoquinoline and peripheral-type benzodiazepine binding in gliomas: implications for diagnostic imaging.

Abstract
Binding of the isoquinoline PK 11195 and of the benzodiazepines Ro5-4864 and flunitrazepam was compared in glioma cells and tissues. In human and rat glioma cell cultures [3H]PK 11195 bound with higher affinity (Kd = 14.01 and 15.76 nM, respectively) than either Ro5-4864 (Ki = 1200 and 84.9 nM, respectively) or flunitrazepam (Ki greater than 10,000 and = 848 nM, respectively). Autoradiograms of postmortem human brain sections containing glioma revealed that [3H]PK 11195 bound specifically to intact tumor cells and not to cells of normal cerebral cortex or necrotic areas of the tumor. Total [3H]Ro5-4864 or [3H]flunitrazepam binding to these sections was indistinguishable from nonspecific binding, and regions of tumor and normal brain could not be delineated. These results support the use of radiolabeled PK 11195 for clinical trials of imaging human gliomas by positron emission tomography.
AuthorsJ M Olson, L Junck, A B Young, J B Penney, W R Mancini
JournalCancer research (Cancer Res) Vol. 48 Issue 20 Pg. 5837-41 (Oct 15 1988) ISSN: 0008-5472 [Print] United States
PMID3262414 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Benzodiazepinones
  • Isoquinolines
  • Benzodiazepines
  • 4'-chlorodiazepam
  • Flunitrazepam
  • PK 11195
Topics
  • Benzodiazepines (metabolism)
  • Benzodiazepinones (metabolism)
  • Brain Neoplasms (diagnostic imaging, metabolism)
  • Cells, Cultured
  • Flunitrazepam (metabolism)
  • Glioma (diagnostic imaging, metabolism)
  • Humans
  • Isoquinolines (metabolism)
  • Kinetics
  • Tomography, Emission-Computed

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: